Insulin

Half-Life (t½)
SC: 1h · IV: 6m
Formula
C256H381N65O77S6
Molecular Weight
5808 g/mol
PubChem CID
70678557
Aliases
Humulin, Novolin, Lantus (glargine), Tresiba (degludec)

Pharmacological Mechanism

51-residue disulfide-bridged peptide hormone. Binds insulin receptor (RTK) → GLUT4 translocation → glucose uptake + glycogen + fat + protein synthesis. Many analogs: rapid-acting (lispro, aspart, glulisine), short (regular), intermediate (NPH), long (glargine, detemir, degludec). Analogs vary by fatty-acid acylation, pI shift, or amino-acid substitution.

Half-Life & Elimination Curve (SC: 1h · IV: 6m)

100%50%25%12.5%0%0h0×t½1h1×t½2h2×t½3h3×t½4h4×t½5h5×t½0×t½ (0h): 100% remaining1×t½ (1h): 50% remaining2×t½ (2h): 25% remaining3×t½ (3h): 12.5% remaining4×t½ (4h): 6.3% remaining5×t½ (5h): 3.1% remaining
Elimination (SC)
  • 0×t½0h100%
  • 1×t½1h50%
  • 2×t½2h25%
  • 3×t½3h12.5%
  • 4×t½4h6.3%
  • 5×t½5h3.1%
Elimination t½1h (SC)
Rate Constant (ke)0.693 h⁻¹
Clearance (CL)3.4 L/h
97% Washout (5×t½)5h

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References